Standout Papers
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial (2001)
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection (2009)
- Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial (2010)
Immediate Impact
34 by Nobel laureates 17 from Science/Nature 127 standout
Citing Papers
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
A genomic region associated with protection against severe COVID-19 is inherited from Neandertals
2021 StandoutNobel
Works of Kenneth Koury being referenced
Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches
2022
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kenneth Koury | 5441 | 6175 | 838 | 27 | 6.6k | |
| Robert Reindollar | 5775 | 6534 | 891 | 33 | 7.0k | |
| Fernando Lopes Gonçales | 4892 | 5606 | 745 | 41 | 6.0k | |
| Jian Yu | 4131 | 4784 | 639 | 12 | 5.1k | |
| George Marinos | 6046 | 6836 | 914 | 61 | 7.8k | |
| Doris B. Strader | 5064 | 4896 | 604 | 35 | 6.3k | |
| Coleman I. Smith | 7749 | 6449 | 753 | 52 | 9.6k | |
| M J Alter | 4518 | 5005 | 798 | 55 | 6.0k | |
| E. Jenny Heathcote | 6898 | 7037 | 885 | 66 | 7.8k | |
| Daniel Lavanchy | 5534 | 5416 | 774 | 65 | 6.8k | |
| Savino Bruno | 5547 | 5771 | 622 | 132 | 6.9k |
All Works
Loading papers...